Page results
-
The National Hospital for Neurology and Neurosurgery (NHNN), part of UCLH NHS Foundation Trust, has been reaccredited under the prestigious Royal College of Anaesthetists (RCoA) Anaesthesia Clinical Services Accreditation (ACSA) demonstrating the hospital anaesthetists’ commitment to patient safety and excellence of care.
-
Five cases of Alzheimer’s disease are believed to have arisen as a result of medical treatments decades earlier, reports a team of UCL and UCLH researchers.
-
Information for patients having a mediastinoscopy / mediastinotomy procedure.
-
From the 23rd January, there will be a staggered rollout of the Tandem t:slim™ 7.7 Control IQ software.
-
Information for patients having a surgery via median sternotomy.
-
Experts from across the world, led by UCLH and UCL clinicians and scientists, have created a framework to guide the introduction of new and advanced robots for surgical procedures.
-
A large study looking at the experiences of people across England after giving birth by Caesarean section has highlighted disparities in outcomes between patients of different ethnic groups.
-
Patient information for patients having a thymectomy procedure.
-
UCLH is making the change from single use to named reusable fabric theatre hats for staff working in operating theatres.
-
UCLH has treated the first brain cancer patient with immunotherapy prior to standard treatment as part of a pioneering trial.
File results
-
FOI/2023/0315 - Menopause Lead at the Trust
-
FOI/2023/0319 - Multiple Sclerosis (MS) treatment/ medication for any diseases
-
FOI/2023/0323 - Medications/ treatment for dermatology and respiratory medicine
-
FOI/2023/0326 - Risk management system reporting rates for adverse events
-
FOI/2023/0327 - NHS long-term plan/ prevention strategy
-
FOI/2023/0330 - Outsourced/ in-house occupational health provisions
-
FOI/2023/0336 - Number of pagers currently in use at the Trust
-
FOI/2023/0337 - Trac systems e-recruitment software used at the Trust
-
FOI/2023/0342 - Self-administration of medication policies
-
FOI/2023/0343 - Clinical guidelines - group B Streptococcus for antenatal, intrapartum and postnatal care